Samsrita Labs Ltd Stock Price Today (NSE: SAMSRITA)
Fundamental Score
Samsrita Labs Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Samsrita Labs Ltd share price today is ₹14.53, down 1.02% on NSE/BSE as of 1 June 2026. Samsrita Labs Ltd (SAMSRITA) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹48.45 (Cr). The 52-week high for SAMSRITA share price is ₹26.04 and the 52-week low is ₹13.78. The company has a Return on Equity (ROE) of -2.31% and a debt-to-equity ratio of 0.11.
Samsrita Labs Ltd Share Price Chart — NSE/BSE Historical Performance
Samsrita Labs Ltd share price chart: -17.85% return over the past month. 52-week high ₹26.04, 52-week low ₹13.78.
Samsrita Labs Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹14.81 | ₹15.50 | ₹14.07 | ₹14.08 | 10.86K (Cr) | |
| ₹14.85 | ₹15.83 | ₹14.75 | ₹14.81 | 13.02K (Cr) | |
| ₹15.45 | ₹15.52 | ₹15.44 | ₹15.52 | 2.80K (Cr) | |
| ₹15.37 | ₹16.36 | ₹15.37 | ₹16.25 | 7.31K (Cr) | |
| ₹16.90 | ₹16.90 | ₹15.30 | ₹16.17 | 3.07K (Cr) | |
| ₹16.24 | ₹16.24 | ₹14.78 | ₹16.10 | 2.69K (Cr) | |
| ₹16.40 | ₹16.50 | ₹15.40 | ₹15.55 | 4.30K (Cr) | |
| ₹16.00 | ₹16.24 | ₹14.88 | ₹16.21 | 3.09K (Cr) | |
| ₹15.11 | ₹15.65 | ₹15.01 | ₹15.65 | 2.23K (Cr) | |
| ₹15.99 | ₹15.99 | ₹14.63 | ₹15.79 | 6.27K (Cr) |
Samsrita Labs Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹17.16 | ₹17.48 | ₹14.07 | ₹14.08 | -17.95% | |
| ₹16.65 | ₹19.00 | ₹14.20 | ₹16.58 | -0.42% | |
| ₹17.71 | ₹18.95 | ₹13.78 | ₹15.86 | -10.45% | |
| ₹19.49 | ₹20.90 | ₹15.32 | ₹17.33 | -11.08% | |
| ₹20.76 | ₹20.76 | ₹16.85 | ₹18.21 | -12.28% | |
| ₹21.85 | ₹24.50 | ₹19.36 | ₹20.76 | -4.99% | |
| ₹22.00 | ₹25.27 | ₹19.07 | ₹21.40 | -2.73% | |
| ₹19.05 | ₹22.65 | ₹16.05 | ₹22.00 | +15.49% | |
| ₹19.21 | ₹21.47 | ₹17.54 | ₹19.05 | -0.83% | |
| ₹25.03 | ₹26.04 | ₹19.60 | ₹19.60 | -21.69% | |
| ₹20.30 | ₹25.54 | ₹17.93 | ₹25.03 | +23.30% | |
| ₹20.85 | ₹24.16 | ₹19.23 | ₹20.30 | -2.64% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Samsrita Labs is a micro-cap turnaround story with a high risk of failure and questionable management execution.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Samsrita Labs announced a strategic expansion into the pet animal healthcare and wellness segment. The trading window was closed ahead of Q4 FY26 results. Samsrita Labs' share price
CORE STORY (THE REAL GAME)
Samsrita Labs is attempting a pivot from a struggling human biopharma business into the higher-growth, higher-margin pet healthcare space. Market is skeptical, given the lack of execution track record and continued losses.
- Strategic expansion into pet healthcare
- Increase in retail holding
- Technical bounce from 52 week low
- Successful launch of pet healthcare products
- Positive Q4 FY26 results
- Significant order wins in the pet healthcare segment
- Micro/SME cap: liquidity risk is high
- Negative Free Cash Flow of ₹-0.67 Cr
- Promoter holding decreasing
Promoters decreased holdings from 31.41% to 25.44% in Dec 2025 quarter.
Indian healthcare is moving towards a technology-driven ecosystem.
No. Free Cash Flow 5Y: ₹-0.67 Cr.
The pet healthcare pivot is a high-risk, high-reward strategy. Success hinges on execution, which is a major question mark.
Primary Thesis Risk
Inability to successfully pivot to pet healthcare will lead to value erosion.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Samsrita Labs Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Samsrita Labs Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SAMSRITA across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Conservative Debt Levels (D/E: 0.11)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Below-Average Return on Equity (-2.31%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-1.80%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Negative Free Cash Flow (₹-0.67 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Samsrita Labs Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Samsrita Labs Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Samsrita Labs LtdSamsrita Labs L...Selected✓ SAMSRITA • 539267 | 0/100 | ₹14.53₹15 | ₹48.45₹48.45 | — — | -2.31%Poor -2.31% Poor | -1.80%Poor -1.80% Poor | 0.11Excellent 0.1 Excellent | 13.20%Good 13.20% Good | — — | 0.00% |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 64.3/100 | ₹1577.30₹1577 | ₹25557.40₹25557.40 | 47.83Average 47.8 Average | 24.30%Excellent 24.30% Excellent | 28.88%Excellent 28.88% Excellent | 0.07Excellent 0.1 Excellent | 16.69%Excellent 16.69% Excellent | 13.09%Good 13.09% Good | 0.79% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 53.7/100 | ₹1240.90₹1241 | ₹10272.45₹10272.45 | 67.39Average 67.4 Average | 19.00%Good 19.00% Good | 20.91%Excellent 20.91% Excellent | 0.42Excellent 0.4 Excellent | 18.97%Excellent 18.97% Excellent | 15.00%Excellent 15.00% Excellent | 0.20% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 48.9/100 | ₹540.85₹541 | ₹10124.28₹10124.28 | 63.98Average 64.0 Average | 11.53%Average 11.53% Average | 14.66%Average 14.66% Average | 0.14Excellent 0.1 Excellent | -0.56%Poor -0.56% Poor | 9.22%Good 9.22% Good | 0.20% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 40.5/100 | ₹522.35₹522 | ₹7724.80₹7724.80 | 60.48Average 60.5 Average | 16.15%Good 16.15% Good | 24.78%Excellent 24.78% Excellent | 0.05Excellent 0.1 Excellent | -0.64%Poor -0.64% Poor | 9.62%Good 9.62% Good | 1.44% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 39.6/100 | ₹541.60₹542 | ₹2626.09₹2626.09 | 30.73Average 30.7 Average | 9.29%Poor 9.29% Poor | 12.52%Average 12.52% Average | 0.30Excellent 0.3 Excellent | 22.05%Excellent 22.05% Excellent | 21.41%Excellent 21.41% Excellent | 0.34% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 47.1/100 | ₹281.70₹282 | ₹1534.08₹1534.08 | 48.05Average 48.0 Average | 16.46%Good 16.46% Good | 17.84%Good 17.84% Good | 0.51Good 0.5 Good | 16.38%Excellent 16.38% Excellent | 9.86%Good 9.86% Good | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 66.1/100 | ₹1105.25₹1105 | ₹1080.56₹1080.56 | 22.01Average 22.0 Average | 19.40%Good 19.40% Good | 25.75%Excellent 25.75% Excellent | 0.00Excellent 0.0 Excellent | 44.03%Excellent 44.03% Excellent | 27.29%Excellent 27.29% Excellent | 0.32% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 69.5/100 | ₹467.55₹468 | ₹1070.08₹1070.08 | 24.39Average 24.4 Average | 42.31%Excellent 42.31% Excellent | 56.38%Excellent 56.38% Excellent | 0.00Excellent 0.0 Excellent | 128.82%Excellent 128.82% Excellent | — — | 0.00% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 40.3/100 | ₹307.25₹307 | ₹1042.27₹1042.27 | — — | 4.63%Poor 4.63% Poor | -1.33%Poor -1.33% Poor | 0.01Excellent 0.0 Excellent | 23.31%Excellent 23.31% Excellent | 24.47%Excellent 24.47% Excellent | 0.00% |
46.5/100 | ₹228.70₹229 | ₹826.72₹826.72 | 30.47Average 30.5 Average | 27.08%Excellent 27.08% Excellent | 28.85%Excellent 28.85% Excellent | 0.48Excellent 0.5 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price25557.40 Cr
- Vijaya Diagnostic Centre Ltd share price10272.45 Cr
- Metropolis Healthcare Ltd share price10124.28 Cr
- Thyrocare Technologies Ltd share price7724.80 Cr
- Krsnaa Diagnostics Ltd share price2626.09 Cr
Samsrita Labs Ltd PE Ratio History
Historical price-to-earnings ratio for SAMSRITA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2022 | ₹1.01 | ₹31.25 | 30.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Samsrita Labs Ltd Quarterly Performance
Latest quarterly metrics for SAMSRITA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
N/A
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
13.20%
Compounded annual net profit growth over 5 years
Samsrita Labs Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SAMSRITA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Samsrita Labs Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Samsrita Labs Ltd (SAMSRITA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Samsrita Labs Ltd
About SAMSRITA (Samsrita Labs Ltd)
Samsrita Labs Ltd is a pioneering healthcare service provider dedicated to revolutionizing diagnostics through advanced molecular technologies. We are committed to empowering healt...hcare professionals with precise and actionable insights, enabling personalized treatment plans and improved patient outcomes. Our state-of-the-art laboratory is equipped with cutting-edge instrumentation, allowing us to perform a comprehensive range of genetic and genomic analyses. From early disease detection to targeted therapy selection, Samsrita Labs strives to be at the forefront of diagnostic innovation, delivering reliable and timely results that contribute to better healthcare decision-making. We believe that personalized medicine is the future and we are passionate about making it accessible to all. At Samsrita Labs, our expertise lies in providing a wide spectrum of sophisticated testing services, tailored to meet the diverse needs of clinicians and patients. We specialize in advanced molecular diagnostics, offering a comprehensive suite of tests covering various disciplines. Our services include high-resolution gene sequencing, advanced molecular diagnostic assays, and cutting-edge bioinformatics analysis. Our commitment to quality and accuracy is unwavering, as we adhere to stringent quality control measures and participate in external proficiency testing programs. Our goal is to empower healthcare professionals with the tools they need to make informed decisions, leading to more effective and personalized treatments. Our extensive testing menu encompasses a broad range of applications, including personalized oncology, pharmacogenomics, infectious disease diagnostics, genetic disorder screening, transplantation compatibility testing, and prenatal genetic screening. Samsrita Labs utilizes advanced technologies such as quantitative PCR (qPCR), Sanger sequencing, and Next-Generation Sequencing (NGS) to deliver accurate and comprehensive results. We are dedicated to providing timely and reliable services, ensuring that our clients have access to the information they need to provide the best possible care. We are driven by a passion for scientific advancement and a commitment to improving the lives of patients through innovative diagnostic solutions.
Company Details
Key Leadership
Latest News
SAMSRITA Share Price: Frequently Asked Questions
What is the current share price of Samsrita Labs Ltd?
Samsrita Labs Ltd (SAMSRITA) trades at ₹14.53 on NSE and BSE. Market cap ₹48.45 (Cr). Educational data only.
What is the P/E ratio of Samsrita Labs Ltd?
Samsrita Labs Ltd has a P/E of N/Ax vs industry average 39.28x.
What is the Bull Run score for Samsrita Labs Ltd?
Samsrita Labs Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Samsrita Labs Ltd pay dividends?
Samsrita Labs Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Samsrita Labs Ltd?
Samsrita Labs Ltd has ROE of -2.31%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Samsrita Labs Ltd?
Samsrita Labs Ltd has debt-to-equity of 0.11.
Is Samsrita Labs Ltd a good investment?
Bull Run gives Samsrita Labs Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.